8月22日奥浦迈发布2025半年度分配预案，拟10派2.3元（含税），预计派现金额合计为2611.62万元。派现额占净利润比例为69.56%，这是公司上市以来，累计第6次派现。
公司上市以来历次分配方案一览
日期分配方案派现金额合计（亿元）股息率（%）2025.06.3010派2.3元（含税）0.260.572024.12.3110派2元（含税）0.230.542024.06.3010派2.2032元（含税）0.250.562023.12.3110派2.304元（含税）0.260.362023.06.3010派2.1元（含税）0.240.242022.12.3110转增4派6元（含税）0.490.50证券时报•数据宝统计显示，公司今日公布了半年报，共实现营业收入1.78亿元，同比增长23.77%，实现净利润3754.69万元，同比增长55.55%，基本每股收益为0.33元。
资金面上看，该股今日主力资金净流出543.27万元，近5日主力资金净流出418.60万元。
两融数据显示，该股最新融资余额为1.10亿元，近5日增加313.44万元，增幅为2.93%。
按申万行业统计，奥浦迈所属的医药生物行业共有33家公司公布了2025半年度分配方案，派现金额最多的是药明康德，派现金额为10.03亿元，其次是东阿阿胶、华润三九，派现金额分别为8.17亿元、7.51亿元。（数据宝）
2025半年度医药生物行业分红排名
代码简称每10股送转（股）每10股派现（元）派现金额（万元）派现占净利润比例（%）股息率（%）603259药明康德0.003.5100308.3811.720.58000423东阿阿胶0.0012.6981720.6699.942.20000999华润三九0.004.575131.4741.391.10600332白云山0.00465031.6425.851.50000963华东医药0.003.561390.7433.830.92000739普洛药业0.003.483540004.9971.052.34002004华邦健康0.00239457.05101.574.96600750江中药业0.00531749.8060.782.22600535天士力0.002.131372.9540.501.37600161天坛生物0.001.529660.5746.890.73688399硕世生物0.003428516.397142.285.17600211西藏药业0.008.8128396.3250.052.38002223鱼跃医疗0.00220049.5416.670.55603456九洲药业0.00217634.2033.541.42002287奇正藏药0.002.212327.9634.400.94000915华特达因0.00511716.5734.721.72600062华润双鹤0.00110387.5810.650.53688029南微医学0.0059346.2725.720.76688366昊海生科0.0049149.3243.350.72300294博雅生物0.001.57563.7333.570.54002107沃华医药0.001.26926.52155.042.40300453三鑫医疗0.0015222.3845.371.27300595欧普康视0.000.565018.4520.070.35300233金城医药0.0013793.3287.440.59300562乐心医疗0.001.32824.7766.790.87688293奥浦迈0.002.32611.6269.560.57000788北大医药0.000.31787.9617.830.50002907华森制药0.000.351461.5927.090.22688046药康生物0.000.31226.9717.300.23688247宣泰医药0.000.251122.5124.620.24688758赛分科技0.000.261082.8120.180.15300534陇神戎发0.000.2606.6921.700.21300003乐普医疗0.001.6275605.690.881.32宏泰证券提示：文章来自网络，不代表本站观点。
